Funding for this research was provided by:
National Institutes of Health (T32AR07708)
Received: 21 March 2021
Accepted: 28 June 2021
First Online: 14 September 2021
: All mouse studies were approved by the Johns Hopkins University Animal Care and Use Committee according to the guidelines and regulations described in the Guide for the Care and Use of Laboratory Animals (National Academies Press, 2011).
: Not applicable.
: LSM is a full-time employee of Janssen Pharmaceuticals and holds Johnson & Johnson stock. LSM performed all work at his prior affiliation at Johns Hopkins University School of Medicine, and he has received prior grant support from AstraZeneca, Pfizer, Regeneron Pharmaceuticals, and Moderna Therapeutics, was a paid consultant for AstraZeneca and as a scientific advisory board of Integrated Biotherapeutics, which are all developing vaccines or therapeutics against <i>S. aureus</i> infections.